Calaspargase Pegol-Mknl Injection
15 interactions 19 cited referencesCalaspargase pegol-mknl is used with other chemotherapy drugs to treat acute lymphocytic leukemia (ALL; a type of cancer of the white blood cells) in infants, children, and young adults aged 1 month to 21 years old. Calaspargase pegol-mknl is an enzyme that interferes with natural substances necessary for cancer cell g… Read the full Calaspargase Pegol-Mknl Injection drug information page →
Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →
Major
Calaspargase Pegol-Mknl Injection Adenovirus Vaccine Type 4, Live An increased risk of infection by the live vaccine Details Calaspargase Pegol-Mknl Injection Adenovirus Vaccine Type 7, Live An increased risk of infection by the live vaccine Details Calaspargase Pegol-Mknl Injection Cholera Vaccine Ipol An increased risk of infection by the live vaccine Details Calaspargase Pegol-Mknl Injection Ebola Zaire Vaccine, Live An increased risk of infection by the live vaccine Details Calaspargase Pegol-Mknl Injection Influenza Virus Vaccine, Live An increased risk of infection by the live vaccine Details Calaspargase Pegol-Mknl Injection Rotavirus Vaccine, Live An increased risk of infection by the live vaccine DetailsNo interactions on this page match that filter — try the next page or clear the filter.
Check another drug
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist